Suchergebnisse - "Kong, Liang"

PubPharm (3)

1

Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition

enthalten in: Journal of liposome research | 2021

von Cai, F. | Yao, X. | Jing, M. | +8

ErratumIn: J Liposome Res. 2022 Mar;32(1):104. - PMID 35129425

2

RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply

enthalten in: Cancer science | 2020

von Kong, L. | Cai, F. | Yao, X. | +8

3

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC

enthalten in: International journal of nanomedicine | 2020

von Kong, L. | Zhang, S. | Chu, J. | +6

ErratumIn: Int J Nanomedicine. 2021 Dec 14;16:8067-8068. - PMID 34938073

1
[1]